LOGIN

VIWA-1

 

Study Design: International phase II trial, explorative, multicenter, open label, and randomized

 

Patients: treatment naive WM patients

 

Treatment: Venetoclax, Rituximab

 

Status of the Study: patient recruitment started

 

Sponsor: University Hospital of Ulm, PI Christian Buske